165 related articles for article (PubMed ID: 32528682)
1. Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database.
Matsumoto K; Nakao S; Hasegawa S; Matsui T; Shimada K; Mukai R; Tanaka M; Uranishi H; Nakamura M
SAGE Open Med; 2020; 8():2050312120918264. PubMed ID: 32528682
[TBL] [Abstract][Full Text] [Related]
2. Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database.
Oura K; Tanaka M; Matsumoto K; Satake R; Inoue M; Yoshida Y; Wakabayashi W; Hasegawa S; Iwata M; Suzuki T; Maezawa M; Nakao S; Liao J; Iguchi K; Nakamura M
BMC Complement Med Ther; 2024 Mar; 24(1):121. PubMed ID: 38486172
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of Time-to-onset of Interstitial Lung Disease after the Administration of Small Molecule Molecularly-targeted Drugs].
Komada F
Yakugaku Zasshi; 2018; 138(2):229-235. PubMed ID: 29386436
[TBL] [Abstract][Full Text] [Related]
4. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
Hasegawa S; Ikesue H; Nakao S; Shimada K; Mukai R; Tanaka M; Matsumoto K; Inoue M; Satake R; Yoshida Y; Goto F; Hashida T; Nakamura M
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
[TBL] [Abstract][Full Text] [Related]
5. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
[TBL] [Abstract][Full Text] [Related]
6. Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.
Naganuma M; Motooka Y; Sasaoka S; Hatahira H; Hasegawa S; Fukuda A; Nakao S; Shimada K; Hirade K; Mori T; Yoshimura T; Kato T; Nakamura M
SAGE Open Med; 2018; 6():2050312118772475. PubMed ID: 29770217
[TBL] [Abstract][Full Text] [Related]
7. [A possible mechanism of interstitial pneumonia during interferon therapy with sho-saiko-to].
Murakami K; Okajima K; Sakata K; Takatsuki K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):389-94. PubMed ID: 7540698
[TBL] [Abstract][Full Text] [Related]
8. Inverse Association between Metformin and Amiodarone-Associated Extracardiac Adverse Events.
Kinoshita S; Hosomi K; Yokoyama S; Takada M
Int J Med Sci; 2020; 17(3):302-309. PubMed ID: 32132864
[No Abstract] [Full Text] [Related]
9. Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database.
Kanbayashi Y; Uchida M; Kashiwagi M; Akiba H; Shimizu T
Med Oncol; 2022 Sep; 39(12):219. PubMed ID: 36175697
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments.
Nawa H; Niimura T; Yagi K; Goda M; Zamami Y; Ishizawa K
Cancer Rep (Hoboken); 2022 Jan; 5(1):e1402. PubMed ID: 33939324
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of everolimus-induced adverse events using the Japanese real-world database.
Uchida M; Nakano K; Fujiwara M; Uesawa Y; Shimizu T
J Clin Pharm Ther; 2022 Aug; 47(8):1173-1180. PubMed ID: 35316861
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of the oriental herbal medicine Sho-saiko-to on liver cirrhosis and carcinoma.
Lee JK; Kim JH; Shin HK
Hepatol Res; 2011 Sep; 41(9):825-37. PubMed ID: 21682829
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases.
Hatahira H; Abe J; Hane Y; Matsui T; Sasaoka S; Motooka Y; Hasegawa S; Fukuda A; Naganuma M; Ohmori T; Kinosada Y; Nakamura M
J Pharm Health Care Sci; 2017; 3():19. PubMed ID: 28729910
[TBL] [Abstract][Full Text] [Related]
14. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports.
Wakao R; Taavola H; Sandberg L; Iwasa E; Soejima S; Chandler R; Norén GN
Drug Saf; 2019 Dec; 42(12):1487-1498. PubMed ID: 31559542
[TBL] [Abstract][Full Text] [Related]
15. Sai-rei-to-induced lung injury: a case report and brief review of the literature.
Komiya K; Ishii H; Ohama M; Uchida M; Tsubone T; Iwashita T; Miyajima H; Okabe E; Matsumoto T; Matsumoto B; Kadota J
Intern Med; 2012; 51(24):3421-5. PubMed ID: 23257532
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Chisaki Y; Aoji S; Yano Y
Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626
[TBL] [Abstract][Full Text] [Related]
17. [An autopsy case of interstitial pneumonia probably induced by Sho-saiko-to].
Tomioka H; Hashimoto K; Ohnishi H; Fujiyama R; Sakurai T; Tada K; Sakamoto H; Iwasaki H
Nihon Kokyuki Gakkai Zasshi; 1999 Dec; 37(12):1013-8. PubMed ID: 10707545
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group.
Hotta K; Kiura K; Tabata M; Harita S; Gemba K; Yonei T; Bessho A; Maeda T; Moritaka T; Shibayama T; Matsuo K; Kato K; Kanehiro A; Tanimoto Y; Matsuo K; Ueoka H; Tanimoto M
Cancer J; 2005; 11(5):417-24. PubMed ID: 16259873
[TBL] [Abstract][Full Text] [Related]
19. [Acute lymphoblastic leukemia complicated by type C hepatitis during treatment and further by acute interstitial pneumonia due to sho-saiko-to in 7-year-old].
Wada Y; Kubo M
Arerugi; 1997 Nov; 46(11):1148-55. PubMed ID: 9436332
[TBL] [Abstract][Full Text] [Related]
20. [Autoimmune hepatitis with drug-induced pneumonia due to Sho-saiko-to].
Katou K; Mori K
Nihon Kokyuki Gakkai Zasshi; 1999 Aug; 37(8):641-6. PubMed ID: 10496105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
